Droppe is building the most comfortable way to order workwear online. Across Europe, 95 million workers rely on workwear every day—but the way it’s bought is broken. It’s still ordered by someone else, often without context, chosen by price. The result? Something blue, something cheap, and workers who feel ignored. We’re changing that. Instead of fixing procurement from the top down, we’ve built the experience from the ground up—based on how workers actually want to order. Workwear is becoming lifestyle: people want to feel great in it, from 9 to 5 and beyond. With AI, we’re making workwear buying fast, personal, and finally built for the people who wear it. We’re a remote-first team with HQ in Helsinki and teammates across Europe. We care about the craft, move fast, and grow every day—in our product, our work, and ourselves.

OncoImmunity is a bioinformatics company providing unique machine-learning software to identify tumor-specific mutations that can be targeted by a patient’s own immune system (known as neoantigens). The OncoImmunity solution is important because recent breakthroughs in the field of Immuno-Oncology (I-O) such as the development of checkpoint inhibitors and personalized cancer vaccines, clearly demonstrate that a patient’s immune system can be harnessed to successfully treat cancer. The cost of identifying tumor-specific mutations in a patient’s cancer using next-generation sequencing (NGS) is now trivial and this technology will be key to enabling truly personalized immunotherapies to be developed in a technically and economically feasible manner. However, the remaining challenge that currently limits the field, and which is addressed by the OncoImmunity solution, is predicting which tumor-specific mutations can stimulate a patient’s immune system i.e. are immunogenic. Using NGS data as input, the OncoImmunity software enables accurate patient selection for cancer immunotherapy and can identify optimal targets for personalized cancer vaccines & cell therapies in a clinically actionable time frame. Beginning from this first product offering, OncoImmunity has the vision to become the world’s leading provider of software to guide cancer immunotherapy to improve survival rates for cancer patients. To achieve this OncoImmunity has assembled a growing team of world-class bioinformaticians, data scientists, and software engineers; developing its cutting-edge machine-learning technology that will help fulfill the promise of immunotherapy in the fight against cancer. OncoImmunity’s technology will disrupt the I-O field by offering regulatory-compliant prediction software on a software-as-a-service basis (SaaS). This will allow big pharma, biotechnology, and immunotherapy companies of any size to access OncoImmunity’s cutting-edge prediction software. The company is headquartered in an ideal scientific and entrepreneurial ecosystem to develop its technology at the Oslo Cancer Cluster Incubator; adjacent to the Institute for Cancer Research and the Norwegian Radium Hospital. OncoImmunity is a privately held company, founded in 2014 by experienced bioinformatics scientists (Dr. Trevor Clancy and Professor Eivind Hovig), and an experienced immunologist with a business development background (Dr. Richard Stratford). The company is backed by private financing from the Norwegian Radium Hospital Research Foundation, the Norwegian Cancer Society, STARTUPLAB, and Grotmol Solutions, in addition to a number of private software investors. The company is also supported by grants awarded from the Norwegian Research Council, Innovation Norway, and the EU. The company has already established both national and international collaborations and pilot projects to develop further proof-of-concept data and validate its software.

CANNORDIC A/S is a Danish-based MedTech company committed to improving people's lives with products that make a difference. We combine science, nature, and passion to deliver innovative alternatives with high efficacy and bioavailability to patients, especially with autoimmune diseases. We research, develop, manufacture, commercialize and brand over-the-counter (OTC) products under pharmaceutical legislation. Currently, 21 products with cannabidiol aimed at autoimmune and stress-related diseases have been developed. The first 2 products reached Danish stores in 2020, and now 9 products are available on the European market at more than 500 points of sale. Another 12 products will be launched before the end of 2024, with 11 patent-pending products. The product line surpasses competing products on the market by being located at the intersection of natural products, science, and cannabinoid technology while certified under pharmaceutical legislation. To learn more about CANNORDIC and the Cannasen® brand, please visit cannordic.com and cannasen.dk

We help our clients to optimize their games and provide them with feature level data on mobile games market. Our online service (SaaS) is based on our patented POWERSCORE® method, which is a missing link between games features and its revenue potential. We work with companies of all sizes, ranging from the biggest game companies in the world to smaller start-up teams. We have a global client base and operate in all regions.

Uizard is the easiest collaborative design tool for non-designers — powered by AI. We are on a quest to empower anyone to create digital products, regardless of their design or technical background. Over the last few years, we have seen a dramatic increase in the need for people outside of design to be able to contribute ideas. Unfortunately, all current design tools are targeting designers and have a step learning curve before being able to fully utilize them. Uizard is the design tool for non-designer allowing anyone to communicate their ideas easily and bridging the gap between the design departments and the rest of the company.

The AuroraX loans exchange connects creditworthy borrowers with investors who seek a higher yield and a moderate risk profile.  AuroraX has the simplest, lowest and most transparent cost structure in the loan market, and a loans aftermarket in the same exchange.  Through its partnerships, AuroraX offers complimentary payment protection insurance, state of the art, PSD2-ready credit rating and safekeeping of funds in regulated financial institutions.

Trine offers a digital investment platform where individuals can invest in solar energy projects. The investment functions as a loan to local entrepreneurs in developing countries. Private investors get return on their investments while contributing to providing life-changing electricity to the 1 billion people without access today. The investment will benefit the investor, local entrepreneurs and reduce the CO2 footprint through green energy. We are constantly amazed by how different we are. Everyone is different. We have very diverse backgrounds, characteristics, interests, and competencies. We complement each other very well! At Trine, we have pretty clear responsibilities, and our work is based on trust: we trust each other to do the job that needs to be done. We respect each other's skills, and everyone has a saying. We work with our three values: people, planet and profit. We do what we do to contribute to better quality of life for people, to reduce the C02 footprint on the world and to make this a profitable business. These three words are incorporated in everything we do, both internally and externally. We never compromise on any of them. We spend most of our time at the office, even though we do offer flexibility. Every Friday is Triday: a day free from meetings to offer everyone the opportunity to work from home, from a café, to catch up on some emails or take the time to read some inspiring articles. We need to gain new perspectives all the time and be open to new strategies.

TEC OUT - exterior furnishing.TEC OUT makes outdoor scandinavian innovative design with high technical performance in colorful durable textiles.When investing in a TEC OUT product, one can assume it is weatherproof, have a flexible use and is thought through to the smallest detail. This means that the products can be used for many years in a sustainable manner.TEC OUT was established in 2015 by three creative entrepreneurs. The team consists of three very dedicated, hard-working and creative people; Lene Egyl, Rikke Borg-Lauritsen and Martin Stoltze.Working at TEC OUT means working with some really skilled people, who love what they do. We take pride in getting things done and still having fun while doing it. We are very curious and constantly work to improve and innovate new products. Our core value is that claimed quality must be equal to experienced quality.

Raido er en almennyttig forening (NGO), der formidler faglig viden og praksisnære værktøjer til undervisere og vejledere på tværs af uddannelsesinstitutioner. Raido har siden 2020 samarbejdet med uddannelsesinstitutioner om at styrke læring, trivsel og gennemførsel for unge og unge voksne. Med RaidoLearn samler vi praksisnær viden fra forskere, praktikere og unge erfaringseksperter i én læringsplatform, der giver undervisere, vejledere og ledere nem adgang til konkrete værktøjer, faglig opdatering og stærke professionelle fællesskaber.

I Returnflows er vi i fuld gang med at bygge fremtidens returflow: Det indebærer komplekse systemintegrationer, skalerbar arkitektur, skarpt design, nytækning, nørderi indenfor logistik, fragt, indfortoldning og en masse problemknusning. Derfor er vi altid på udkig efter ligesindede, der – ligesom os – ved, at nysgerrighed og skæve tanker skaber nyt potentiale. Som elsker at nørde med teknologi – måske endda ikke kan lade være – og som omfavner udviklingen, der gør, at i morgen bliver lidt bedre end i dag.

Business Angels Norway is the only umbrella assocation for regional or industry-specific angel groups in Norway. We are a co-founder of NordicBAN, the Nordic-Baltic assocation for business angels. We have ca 10 angel groups all over Norway, with >500 business angels total. We are an interest assocation, working for the interests of angel groups and business angels in general. We are part of several international initiatives and projects, incl the Nordic Angel Program where we need YOU!

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

Qt Group (Nasdaq Helsinki: QTCOM) is a global software company with a strong presence in more than 70 industries and is the leading independent technology behind millions of devices and applications. Qt is used by major global companies and by over one million developers worldwide, and the technology enables its customers to deliver exceptional user experiences and advance their digital transformation initiatives. We enable a single software code across all operating systems, platforms and screen types, from desktops and embedded systems to business-critical applications, in-vehicle systems, wearables and mobile devices connected to the Internet of Things. Qt employs some 550 people and operates in China, Finland, Germany, Japan, South Korea, Norway, Russia, the USA, France, UK, Italy and India.

Northe is a tech startup developing the most optimized platform for the EV charging industry. The platform makes it possible for fleets, private drivers and charge box owners to drive, charge and own EV charging without having to deal with the complex and fragmented market. We tackle and solve the larger complex picture through our fleet charge management, our charge box payments solution and our drivers app. These features combined generates a complete solution and a seamless connection within the parties of the industry. The platform combines both semi/public and public charging and makes it hassle free for consumers, leasing companies, car sharing, taxi, rental firms and all other organizations driving electric or investing in charging infrastructure. The EV industry is young and so is Northe – the company is developing fast and constantly launching new features and services. Partners and customers are therefore able to contribute to what is becoming the future of this booming market.

For everyone and anyone who wants to create great value, and become the best version of themselves. We're a Swedish founded startup for talented people, searching for their next great experience. Our culture is circling around making every employee, intern and consultant, become the best version of themselves. After all, that is what we do for our customers, everyday. Zaplify is the tool for finding the most relevant people, enrich profiles with insightful data and reach out to B2B contacts in a social & personal, yet effective way. Streamlining customer & talent acquisition. Making warm leads easy. If you want to challenge old, traditional structures, create great value and become the best version of yourself, you belong with Zaplify.